A comprehensive view of Illnesses/Symptoms/Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch: Covid-19 vaccine sales saw strong start to 2022, with Pfizer and Moderna posting stronger-than-expected Q1 sales; 2022 sales could be comparable to significant 2021 numbers, but estimates for 2023 should see more pronounced decrease in market size
Published: June 23, 2022 by Fitch Solutions Sector Intelligence
Bill Gates sees 50% chance of new pandemic in next 20 years, says mortality rate raised to 5% could be 'end of society' versus COVID's 0.2% mortality rate; solution to prevent next pandemic would cost US$1B/year, compared to US$14B lost to pandemic so far
Published: June 09, 2022 by CE Noticias Financieras
Cantor Fitzgerald expects sales of COVID vaccines and therapeutics to plateau on slowing demand, adequate supplies in many nations; meanwhile, people have opted for boosters at lower rate than they received initial vaccine regimens, further hurting demand
Published: June 07, 2022 by Indian Health Care News
Tech vs. Trees: 3D-printed wooden beehives aim to support bee populations, UK studio reimagines COVID-19 rapid test as paper-based and biodegradable, student spending on print textbooks down as much as 69% in last decade
Published: May 31, 2022 by Industry Intelligence Inc.
BofA initiates Novavax with underperform rating, noting firm’s sales projections for COVID vaccine are below consensus given bearish outlook on continued booster use, uncertain benefits as a differentiated option, drop in immunity against new variants
Published: May 26, 2022 by Indian Health Care News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count